Ads
related to: medications for exocrine pancreatic insufficiency
Search results
Results from the WOW.Com Content Network
Exocrine pancreatic insufficiency (EPI) is the inability to properly digest food due to a lack or reduction of digestive enzymes made by the pancreas.EPI can occur in humans and is prevalent in many conditions [1] such as cystic fibrosis, [2] Shwachman–Diamond syndrome, [3] different types of pancreatitis, [4] multiple types of diabetes mellitus (Type 1 and Type 2 diabetes), [5] advanced ...
Pancrelipases are generally a first line approach in treatment of exocrine pancreatic insufficiency and other digestive disorders, accompanying cystic fibrosis, complicating surgical pancreatectomy, or resulting from chronic pancreatitis. The formulations are generally hard capsules filled with gastro-resistant granules. Pancrelipases and ...
The most common pancreatic disease is pancreatitis, an inflammation of the pancreas which could come in acute or chronic form. Other pancreatic diseases include diabetes mellitus, exocrine pancreatic insufficiency, cystic fibrosis, pseudocysts, cysts, congenital malformations, tumors including pancreatic cancer, and hemosuccus pancreaticus
Damage to the pancreas can reduce the production of pancreatic enzymes that aid digestion, causing Exocrine Pancreatic Insufficiency. Fats and nutrients are not absorbed properly, leading to loose, greasy stool known as steatorrhea. It can also lead to malnutrition. [1] [2] Weight loss even when eating habits and amounts are normal. [1]
Type 3c diabetes (also known as pancreatogenic diabetes) is diabetes that comes secondary to pancreatic diseases, [1] involving the exocrine and digestive functions of the pancreas. It also occurs following surgical removal of the pancreas. Around 5–10% of cases of diabetes in the Western world are related to pancreatic diseases.
In chronic pancreatitis, the fecal pancreatic elastase-1 (FPE-1) test is a marker of exocrine pancreatic function. Additional tests that may be useful in evaluating chronic pancreatitis include hemoglobin A1C , immunoglobulin G4 , rheumatoid factor , and anti-nuclear antibody .
Liprotamase (Sollpura), Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency is currently in Phase 3 clinical trials, and A-623 for the treatment of IgA nephropathy [1] [2] is currently in Phase 2 clinical trial.
Treatment is dependent on the phenotype. Hyperglycaemia can be treated with insulin, oral medication or, according to newest data, with GLP-1 analogs. Sulfonylurea has been described as ineffective. Pancreatic exocrine insufficiency is treated with pancreatic enzymes such as Kreon. Some patients take magnesium supplementation or intravenous ...
Ads
related to: medications for exocrine pancreatic insufficiency